Sala, Farnea .

HRN: 07-14-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/16/2026
02/17/2026
IV
1g
PTOR
Stat CS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: